FutureFuel Corp. announced it will release its third quarter 2026 financial results after the U.S. market closes on November 9, 2026. The company will hold a conference call on November 10, 2026, to discuss the results, recent events, and answer questions. FutureFuel is a manufacturer of custom and performance chemicals and biofuels, and this update provides investors insight into its financial health and business progress. The webcast and teleconference details are available on the company's website for interested participants.
FutureFuel's upcoming Q3 2026 results call provides context for readers. For those tracking Basic Materials, 70 of 83 US stocks rose on Pluang today. Notable movers include Standard Lithium Ltd at USD 1.48 (+5.71%), Novagold Resources Inc. at USD 6.32 (+5.69%), and Hudbay Minerals Inc. at USD 23.32 (+5.23%). Data as of Oct 28, 2026 02:21 WIB.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Eli Lilly has outpaced Novo Nordisk in the GLP-1, obesity, and Type 2 Diabetes market, achieving a $1.21 trillion valuation. While Novo Nordisk's share price has fallen back after earlier gains and revenue growth remains flat, its management's strate...
argenx SE announced it will stop its Phase 3 UNITY study of efgartigimod subcutaneous for moderate-to-severe Sjögren's disease after an independent committee found the trial unlikely to meet its primary goal. This decision caused the company's stock ...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a sharp stock price drop triggered by a new U.S. federal strategy targeting the dialysis market. The Department of Health and Human Services announced a plan to incre...
Pomerantz LLP is investigating ClearPoint Neuro and its executives for possible securities fraud following a significant stock price drop. The decline occurred after ClearPoint's partner, uniQure, announced that their Huntington's disease treatment f...
